Home › Gastro-enteropancreatic neuroendocrine tumor › Texas
Gastro-enteropancreatic neuroendocrine tumor clinical trials in Texas
3 studies for Gastro-enteropancreatic neuroendocrine tumor are looking for participants at sites in Texas.
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
- University of Texas - MD Anderson Cancer Center, Houston
RecruitingPhase 1
24 Months – 18 Years · All sexes · Updated Sep 25, 2026 · NCT06441331Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
- Texas Oncology, Dallas
RecruitingPhase 3
Ages 12 to 100 · All sexes · Updated Sep 11, 2026 · NCT06784752Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine Tumors
- Clinical Research Institute at Methodist Health System, Dallas
RecruitingObservational study
Ages 18 and older · All sexes · Updated Mar 20, 2026 · NCT04090034From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.